RADX (Radiopharm Theranostics Limited) Stock Price

This chart of the market price for Radiopharm Theranostics (RADX) serves as an indicator for a business that relies on the precision of targeted radiotherapy and stable isotope supplies from reactors for its own developments. The current metric stands at 0.77. The company's success is based on a staff of rare specialists attracted by cutting-edge laboratories, competitive compensation, and the opportunity to conduct exclusive scientific research.

RADX - Radiopharm Theranostics Ltd Share Price over the range 12/06/2024 - 11/15/2026

Metric breakdowns and analytics for Radiopharm Theranostics Limited (RADX)

- stock value and consensus price forecast:

Price Chart Radiopharm Theranostics|RADX - Fair Value Consensus

- business market valuation indicators:

Market Capitalization Radiopharm Theranostics|RADX - Enterprise Value

- book capitalization information:

Book Value per Share Radiopharm Theranostics|RADX - Accounting Capitalization|Market Cap to Net Assets Ratio radiopharmtheranostics.com|RADX - Total Business Assets

- company liabilities and liquidity data:

Total Debt to Capital Radiopharm Theranostics|RADX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Radiopharm Theranostics Ltd|RADX - Company Aggregate Debts|Debt to Book Capitalization Ratio Radiopharm Theranostics Limited|RADX - Company Long-Term Indebtedness|Company Short-Term Debts Radiopharm Theranostics|Quick Ratio radiopharmtheranostics.com

- earnings and market ratios statistics:

RADX - Company Net Income|Expected Profit Radiopharm Theranostics|RADX - Company Value to Net Income|Projected Price to Earnings Radiopharm Theranostics|RADX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Radiopharm Theranostics|RADX - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Radiopharm Theranostics|RADX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months radiopharmtheranostics.com|RADX - Earnings per share increase in current year|Earnings growth forecast for next year Radiopharm Theranostics

- sales revenue and business income indicators:

RADX - Company Total Revenue|Company Projected Revenue Radiopharm Theranostics Limited|RADX - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Radiopharm Theranostics

Comprehensive company analysis:RADX Radiopharm Theranostics

To identify the fundamental leaders of the sector, the analyst evaluates price as an integral result of market consensus, reflecting capitalization dynamics by comparing current quotes with historical extremes. In the case of Radiopharm Theranostics (RADX), this market value vector visualizes investor expectations regarding the monetization of unique patents for targeted isotope delivery, converting high therapy premiums into the specific value of a single share.

Who Radiopharm Theranostics competes with